This HTML5 document contains 77 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
dctermshttp://purl.org/dc/terms/
dbohttp://dbpedia.org/ontology/
foafhttp://xmlns.com/foaf/0.1/
dbpedia-eshttp://es.dbpedia.org/resource/
n16https://global.dbpedia.org/id/
schemahttp://schema.org/
dbthttp://dbpedia.org/resource/Template:
n12https://orcid.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
n17http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
wikipedia-enhttp://en.wikipedia.org/wiki/
dbchttp://dbpedia.org/resource/Category:
dbphttp://dbpedia.org/property/
provhttp://www.w3.org/ns/prov#
xsdhhttp://www.w3.org/2001/XMLSchema#
wikidatahttp://www.wikidata.org/entity/
dbrhttp://dbpedia.org/resource/

Statements

Subject Item
dbr:Laura_Soucek
rdf:type
wikidata:Q5 wikidata:Q729 wikidata:Q901 wikidata:Q19088 wikidata:Q215627 dbo:Eukaryote dbo:Scientist n17:NaturalPerson dbo:Animal dbo:Species owl:Thing foaf:Person dbo:Person schema:Person
rdfs:label
Laura Soucek Laura Soucek
rdfs:comment
Laura Soucek (born 1973) is a Group Leader at VHIO (the ), Research Professor at ICREA, and CEO of Peptomyc S.L. She works on the Myc oncoprotein, the deregulation of which occurs during almost all cancers. Soucek has designed a dominant negative variant, Omomyc, which allows her to investigate the benefits of inhibiting Myc in cancer. Laura Soucek (Velletri, 1973) es una investigadora italiana, líder de grupo en el Instituto de Oncología Vall d'Hebron, profesora de investigación en ICREA (siglas en inglés para la ), y CEO de Peptomyc S.L. Trabaja con la oncoproteína Myc, que se desregula cuando el organismo sufre cáncer. Soucek ha diseñado una variante dominante negativa, Omomyc, que le permite investigar los beneficios de inhibir el Myc durante el cáncer.
foaf:name
Laura Soucek
dbp:name
Laura Soucek
dbo:birthPlace
dbr:Velletri
dbp:birthPlace
dbr:Velletri
dcterms:subject
dbc:1973_births dbc:21st-century_Italian_scientists dbc:Living_people dbc:Italian_women_scientists dbc:Sapienza_University_of_Rome_alumni dbc:21st-century_Italian_women dbc:21st-century_women_scientists dbc:People_from_Velletri
dbo:wikiPageID
62249715
dbo:wikiPageRevisionID
1068497818
dbo:wikiPageWikiLink
dbc:Living_people dbr:University_of_California,_San_Francisco dbr:Gerard_Evan dbr:FC_Barcelona dbr:Autonomous_University_of_Barcelona dbc:1973_births dbr:Oncoprotein dbc:21st-century_Italian_scientists dbc:Italian_women_scientists dbr:Vall_d'Hebron_Institute_of_Oncology dbr:Oncogene dbc:21st-century_Italian_women dbc:People_from_Velletri dbc:Sapienza_University_of_Rome_alumni dbc:21st-century_women_scientists dbr:Catalan_Institution_for_Research_and_Advanced_Studies dbr:Non-small-cell_lung_carcinoma dbr:Myc dbr:Barcelona dbr:Velletri dbr:Rome dbr:Sapienza_University_of_Rome dbr:European_Institute_of_Innovation_and_Technology
owl:sameAs
dbpedia-es:Laura_Soucek n12:0000-0002-4750-7971 wikidata:Q48975690 n16:4YC2v
dbp:workplaces
Vall d'Hebron Institute of Oncology, ICREA, UAB
dbp:wikiPageUsesTemplate
dbt:Infobox_scientist dbt:Reflist dbt:Cite_journal dbt:Authority_control
dbp:almaMater
University of California, San Francisco dbr:Sapienza_University_of_Rome
dbp:influences
dbr:Gerard_Evan
dbo:abstract
Laura Soucek (Velletri, 1973) es una investigadora italiana, líder de grupo en el Instituto de Oncología Vall d'Hebron, profesora de investigación en ICREA (siglas en inglés para la ), y CEO de Peptomyc S.L. Trabaja con la oncoproteína Myc, que se desregula cuando el organismo sufre cáncer. Soucek ha diseñado una variante dominante negativa, Omomyc, que le permite investigar los beneficios de inhibir el Myc durante el cáncer. Laura Soucek (born 1973) is a Group Leader at VHIO (the ), Research Professor at ICREA, and CEO of Peptomyc S.L. She works on the Myc oncoprotein, the deregulation of which occurs during almost all cancers. Soucek has designed a dominant negative variant, Omomyc, which allows her to investigate the benefits of inhibiting Myc in cancer.
dbo:institution
dbr:Catalan_Institution_for_Research_and_Advanced_Studies dbr:Vall_d'Hebron_Institute_of_Oncology
prov:wasDerivedFrom
wikipedia-en:Laura_Soucek?oldid=1068497818&ns=0
dbo:wikiPageLength
7973
dbo:almaMater
dbr:Sapienza_University_of_Rome dbr:University_of_California,_San_Francisco
dbo:influencedBy
dbr:Gerard_Evan
foaf:isPrimaryTopicOf
wikipedia-en:Laura_Soucek